Changming Huang

46PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Aug 03, 2026
Midkine-activated TRPA1+ cancer-associated fibroblasts promote immunotherapy resistance in gastric cancer through a WNT5A-mediated treg circuit.

|Jul 19, 2026
Multiomics Analysis Reveals CTHRC1+ CAFs Drive Immunosuppressive Niches and Predict Immunotherapy Resistance in Gastric Cancer.

|Apr 22, 2026
Disrupting SRSF10-dependent BCAT2 exon skipping reprograms tumor-associated macrophages and enhances anti-PD-1 efficacy in gastric cancer.

|Apr 14, 2026
Tff2 marks gastric corpus progenitors that give rise to pyloric metaplasia/SPEM following injury.

Ruhong Tu, Hua-Long Zheng, Biyun Zheng

|Apr 16, 2025
Targeting LHPP in neoadjuvant chemotherapy resistance of gastric cancer: insights from single-cell and multi-omics data on tumor immune microenvironment and stemness characteristics.

You-Xin Gao, Xiao-Jing Guo, Bin Lin

|Mar 07, 2025
Combining Apatinib and Oxaliplatin Remodels the Immunosuppressive Tumor Microenvironment and Sensitizes Desert-Type Gastric Cancer to Immunotherapy.

Guang-Tan Lin, Cheng Yan, Lu-Jie Li

Pageof 8

Frequent Collaborators

20 joint publications

Chaohui Zheng

13 joint publications

Ru-Hong Tu

5 joint publications

Jianwei Xie

4 joint publications

Long-Long Cao